We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Columbus McKinnon
CMCO
$439M
| $2.8M | 0.01% |
194,970
+74,482
| +62% | +$1.12M |
|
|
ALEX
527
DELISTED
Alexander & Baldwin
ALEX
| $2.78M | 0.01% |
152,784
-21,962
| -13% | -$403K |
|
528
Citi Trends
CTRN
$543M
| $2.78M | 0.01% |
+89,542
| New | +$2.9M |
|
529
Editas Medicine
EDIT
$391M
| $2.78M | 0.01% |
800,023
+707,181
| +762% | +$1.97M |
|
530
Regional Management Corp
RM
$388M
| $2.73M | 0.01% |
70,086
+10,595
| +18% | +$399K |
|
531
Kodiak Sciences
KOD
$2.4B
| $2.7M | 0.01% |
165,220
-255,485
| -61% | -$2.2M |
|
532
Community Trust Bancorp
CTBI
$1.43B
| $2.7M | 0.01% |
48,285
+712
| +1% | +$40K |
|
533
Johnson Outdoors
JOUT
$495M
| $2.69M | 0.01% |
66,558
+24,088
| +57% | +$898K |
|
|
534
Lennox International
LII
$15.2B
| $2.69M | 0.01% |
5,077
-327,481
| -98% | -$191M |
|
535
Cogent Biosciences
COGT
$6.79B
| $2.69M | 0.01% |
+187,083
| New | +$2.22M |
|
536
Costamare
CMRE
$1.85B
| $2.67M | 0.01% |
224,177
+151,235
| +207% | +$1.65M |
|
|
GLDD
537
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.66M | 0.01% |
221,743
+56,427
| +34% | +$654K |
|
538
Vital Farms
VITL
$598M
| $2.66M | 0.01% |
64,571
+7,475
| +13% | +$325K |
|
539
MSCI
MSCI
$42.4B
| $2.65M | 0.01% |
4,677
-50,110
| -91% | -$28.3M |
|
540
Miller Industries
MLR
$576M
| $2.65M | 0.01% |
65,488
+30,980
| +90% | +$1.3M |
|
541
RH
RH
$3.24B
| $2.64M | 0.01% |
12,982
+1,509
| +13% | +$328K |
|
542
Donegal Group Class A
DGICA
$715M
| $2.63M | 0.01% |
135,410
+3,100
| +2% | +$56.7K |
|
543
Telos
TLS
$336M
| $2.63M | 0.01% |
383,801
-346,316
| -47% | -$1.65M |
|
544
GoodRx Holdings
GDRX
$1.06B
| $2.55M | 0.01% |
602,905
-226,193
| -27% | -$994K |
|
545
Horace Mann Educators
HMN
$2.13B
| $2.53M | 0.01% |
56,116
-8,119
| -13% | -$357K |
|
546
Ironwood Pharmaceuticals
IRWD
$604M
| $2.52M | 0.01% |
1,920,530
+445,484
| +30% | +$461K |
|
547
Kearny Financial
KRNY
$605M
| $2.51M | 0.01% |
382,268
-187,609
| -33% | -$1.2M |
|
548
Assured Guaranty
AGO
$3.79B
| $2.5M | 0.01% |
29,590
-32,244
| -52% | -$2.68M |
|
549
Koppers
KOP
$939M
| $2.47M | 0.01% |
88,370
-29,153
| -25% | -$897K |
|
550
Forum Energy Technologies
FET
$580M
| $2.47M | 0.01% |
92,614
+71,294
| +334% | +$1.65M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.